France Neurovascular Devices Market Size & Outlook
France neurovascular devices market, 2018-2030 (US$M)
Related Markets
France neurovascular devices market highlights
- The France neurovascular devices market generated a revenue of USD 96.5 million in 2023 and is expected to reach USD 144.5 million by 2030.
- The France market is expected to grow at a CAGR of 5.9% from 2024 to 2030.
- In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device in 2023.
- Support Devices is the most lucrative device segment registering the fastest growth during the forecast period.
Neurovascular devices market data book summary
| Market revenue in 2023 | USD 96.5 million |
| Market revenue in 2030 | USD 144.5 million |
| Growth rate | 5.9% (CAGR from 2023 to 2030) |
| Largest segment | Cerebral embolization and aneurysm coiling devices |
| Fastest growing segment | Support Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cerebral Embolization and aneurysm Coiling devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices |
| Key market players worldwide | Medtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp |
Other key industry trends
- In terms of revenue, France accounted for 3.2% of the global neurovascular devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany neurovascular devices market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 203.4 million by 2030.
Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 34.92% in 2023. Horizon Databook has segmented the France neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.
France neurovascular devices market is anticipated to witness sluggish growth over the forecast period owing to various factors such as growing healthcare spending and rising geriatric population. According to OECD, France spent 11.06% of the GDP on healthcare in 2019.
In addition, according to World Bank, the percentage of population aged 65 and above has increased from 16.85% in 2010 to 20.03% in 2018. Moreover, growing number of research initiatives and increasing investments for the development of novel procedures involving advanced brain devices is expected to contribute to the market growth.
However, low prevalence of acute ischemic stroke and presence of few market players in France are among major factors restraining market growth over the forecast period. In addition, low rate of adoption of technologically advanced products and lack of skilled professionals are among factors expected to negatively impact the market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurovascular Devices Market Scope
Neurovascular Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France neurovascular devices market size, by device, 2018-2030 (US$M)
France Neurovascular Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
